Music-assisted treadmill training in the therapy of Parkinson's disease

Organizational Data

DRKS-ID:
DRKS00017687
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2019-09-25
Last update in DRKS:
2023-02-07
Registration type:
Prospective

Acronym/abbreviation of the study

MATT study

URL of the study

No Entry

Brief summary in lay language

No Entry

Brief summary in scientific language

Parkinson’s Disease (PD) is one of the main neurodegenerative disease in Germany and in western industry nations with increasing number of patients due to the demographic change. In the course of the disease PD patients suffer from motor and non-motor symptoms. Only a limited number of pharmacotherapies for the symptomatic treatment of PD patients are available and so is the invasive deep brain stimulation (DBS), which is limited to a selected group of patients. Inducing an urgent need for alternative, non-pharmacologic therapy options. Motor and cognitive therapies are established treatments, however in the usual care routines they are applied independent (if at all) from on another even though a growing understanding of motor function and cognition as linked entities exists. Furthermore patient’s motivation for long-term adherence can be a challenge in progressive disease. Treadmill training and cueing are successfully applied in routine care of PD patients to improve gait. Patients consider the training with musically auditive cues as especially motivating. A music assisted gait training showed better effects than a usual treadmill training. However, these studies mainly focused on motor functional outcomes, so that a remaining research interest exists to examine the possible effects on cognition. Furthermore, studies rarely include patient-centered outcomes, so that the current project aims at evaluation these. Additionally there is little evidence about the mid-term effects of a music-assisted treadmill training so that these will be evaluated as well. In the current pilot-project with a randomized controlled design and follow-up telephone interview after six weeks, we aim at the evaluation of feasibility as well as short- and mid-term effects of a music-assisted treadmill training on cognition. Furthermore the patient-centered outcomes of mood, motivation, fatigue, and fun will be compared to an usual ergometer training.

Health condition or problem studied

ICD10:
G20 - Parkinson disease
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
20 min music assisted treadmill training plus regular motor and cognitive rehabilitation therapy for 8 training days
Arm 2:
20 min ergometertraining plus regular motor and cognitive rehabilitation therapy for 8 training days

Endpoints

Primary outcome:
Cognition - Overall cognition (MoCA) - Alertness (TAP) - selective Attention (TAP) - reaction time (WTS, RT-S5) - Inhibition (TAP) - cognitive flexibility (TAP; TMT B/A) - word fluency (RWT) - short-term memory (number and Digit span of WMS-R; visual reproduction of WMS-R) - working memory (number and Digit span of WMS-R) - mentale rotation (LPS-2, Subtest 7) - visual scanning (TAP, TMT- A) - learning strateges (CVLT; TOL-D)
Secondary outcome:
Motor Function - gros motor function: Fist Closure Frequency - fine motor function: NHPT - Balance/ risk for falls: BBS; TUG; TUG+DT - gait: 10mGT - Freezing: FoGQ - functional independence: FIM Ability to sychronize Motivation, mood, fatigue und fun while training Disease severity (H&Y; UPDRS) Depression (GDS) Quality of life (PDQ-39; EQ-5D) Activity level (IPAQ) Fatigue (PFS- 16)

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Neurologisches Rehabilitationszentrum Godeshöhe e.V. Bonn- Bad Godesberg

Recruitment period and number of participants

Planned study start date:
2019-10-01
Actual study start date:
2019-09-26
Planned study completion date:
No Entry
Actual Study Completion Date:
2022-11-15
Target Sample Size:
70
Final Sample Size:
70

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
110 Years
Additional Inclusion Criteria:
- Patients with Parkinson's disease - no further neurological or psychiatric disease, that interferes with study participation - no hint at a medium severe depression(cut-off: < 10 Points on Geriatric Depression Scale) - no other disease (cardiologic or orthpedic), that interferes with study participation - undisturbed or sufficiently corrected vision and hearing - Participant speaks German - Patient can provide informed consent (cut-off: Montreal Cognitive Assessment (MoCA) > 17 points; Freitas et al., 2014) - Patient can follow therapeutic instructions - Patient provides written consent for study participation - scheduled stay of at least 14 days at neurological rehabilitations center Godeshöhe e.V.

Exclusion Criteria

- severe disturbtion of vigilance, of speech or psychiatric, which interfere with understanding of study aims and/ or instructions, and decrease safety during - daily uncontrolled changes in medication or Stimulation Settings, which would decrease safety

Addresses

Primary Sponsor

Address:
Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Prof. Dr. rer. nat. Elke Kalbe
Kerpenerstr. 62
50937 Köln
Germany
Telephone:
+49 221 478-6669
Fax:
+49 221 478-3420
Contact per E-Mail:
Contact per E-Mail
URL:
http://neurologie-psychiatrie.uk-koeln.de/medizinische-psychologie
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Prof. Dr. rer. nat. Elke Kalbe
Kerpenerstr. 62
50937 Köln
Germany
Telephone:
+49 221 478-6669
Fax:
+49 221 478-3420
Contact per E-Mail:
Contact per E-Mail
URL:
http://neurologie-psychiatrie.uk-koeln.de/medizinische-psychologie

Contact for Public Queries

Address:
Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
MSc Mareike Gooßes
Kerpenerstr. 62
50937 Köln
Germany
Telephone:
+49 221 478-96250
Fax:
+49 221 478-3420
Contact per E-Mail:
Contact per E-Mail
URL:
http://neurologie-psychiatrie.uk-koeln.de/medizinische-psychologie.

Principal Investigator

Address:
Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Prof. Dr. rer. nat. Elke Kalbe
Kerpenerstr. 62
50937 Köln
Germany
Telephone:
+49 221 478-6669
Fax:
+49 221 478-3420
Contact per E-Mail:
Contact per E-Mail
URL:
http://neurologie-psychiatrie.uk-koeln.de/medizinische-psychologie

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Medizinische Psychologie | Neuropsychologie und Gender Studies und Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Kerpener Str. 62
50937 Köln
Germany
Telephone:
+49 221 478-6669
Fax:
+49 221 478-3420
Contact per E-Mail:
Contact per E-Mail
URL:
http://neurologie-psychiatrie.uk-koeln.de/medizinische-psychologie

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Medizinischen Fakultät der Universität zu Köln
Gleueler Str. 269
50935 Köln
Germany
Telephone:
+49-221-478 82900
Fax:
+40-221-478 82905
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2019-06-13
Ethics committee number:
19-1291
Vote of the Ethics Committee:
Approved
Date of the vote:
2019-07-15

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
U1111-1240-9458
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry